Detalles de la búsqueda
1.
Biochemical Markers of Musculoskeletal Health and Aging to be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia: Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Centre Académique de Recherche et d'Expérimentation en Santé (CARES SPRL), Under the Auspices of the World Health Organization Collaborating Center for the Epidemiology of Musculoskeletal Conditions and Aging.
Calcif Tissue Int;
112(2): 197-217, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36633611
2.
Role of vitamin D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group.
Aging Clin Exp Res;
34(11): 2603-2623, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36287325
3.
Correction: Biochemical Markers of Musculoskeletal Health and Aging to be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia: Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Centre Académique de Recherche et d'Expérimentation en Santé (CARES SPRL), Under the Auspices of the World Health Organization Collaborating Center for the Epidemiology of Musculoskeletal Conditions and Aging.
Calcif Tissue Int;
113(3): 357-358, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37488204
4.
Interdisciplinary management of FGF23-related phosphate wasting syndromes: a Consensus Statement on the evaluation, diagnosis and care of patients with X-linked hypophosphataemia.
Nat Rev Endocrinol;
18(6): 366-384, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35484227
Resultados
1 -
4
de 4
1
Próxima >
>>